Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.41% |
| 2 | Financials | 12.33% |
| 3 | Energy | 10.93% |
| 4 | Industrials | 10.41% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Costamare
CMRE
$1.79B
| $1.03M | ﹤0.01% |
+183,178
| New | +$1.21M |
|
|
OSIR
2227
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $1.03M | ﹤0.01% |
+208,979
| New | +$1.07M |
|
2228
Great Southern Bancorp
GSBC
$857M
| $1.02M | ﹤0.01% |
18,763
+13,665
| +268% | +$647K |
|
|
ECYT
2229
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $1.02M | ﹤0.01% |
401,900
-44,165
| -10% | -$127K |
|
2230
La-Z-Boy
LZB
$1.3B
| $1.02M | ﹤0.01% |
32,938
-156,244
| -83% | -$4.23M |
|
2231
Synaptics
SYNA
$3.74B
| $1.02M | ﹤0.01% |
19,076
-97,459
| -84% | -$5.64M |
|
|
LORL
2232
DELISTED
Loral Space and Communications, Inc.
LORL
| $1.02M | ﹤0.01% |
24,900
-1,676
| -6% | -$65.6K |
|
|
CHUBK
2233
DELISTED
CommerceHub, Inc. Series C Common Stock
CHUBK
| $1.02M | ﹤0.01% |
+67,927
| New | +$1.02M |
|
2234
V2X
VVX
$2.44B
| $1.02M | ﹤0.01% |
+42,720
| New | +$869K |
|
2235
Brown-Forman Class B
BF.B
$12.9B
| $1.02M | ﹤0.01% |
35,414
-326,878
| -90% | -$9.55M |
|
2236
PUT
Nike
NKE
$57.2B
| $1.02M | ﹤0.01% |
+20,000
| New | +$1.03M |
|
|
SWN
2237
CALL
DELISTED
Southwestern Energy Company
SWN
| $1.01M | ﹤0.01% |
93,800
| – | – |
|
|
LEXEA
2238
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $1.01M | ﹤0.01% |
+25,579
| New | +$1.09M |
|
2239
Capitol Federal Financial
CFFN
$1.07B
| $1.01M | ﹤0.01% |
61,621
-12,078
| -16% | -$186K |
|
|
NETI
2240
DELISTED
Eneti Inc.
NETI
| $1.01M | ﹤0.01% |
21,483
+18,469
| +613% | +$777K |
|
|
NVO
2241
Novo Nordisk
NVO
$209B
| $1M | ﹤0.01% |
56,060
-3,014,014
| -98% | -$54.6M |
|
2242
Vanguard Information Technology ETF
VGT
$145B
| $1M | ﹤0.01% |
66,184
+50,176
| +313% | +$756K |
|
2243
International Flavors & Fragrances
IFF
$22.2B
| $1M | ﹤0.01% |
8,510
+4,506
| +113% | +$565K |
|
2244
Healthpeak Properties
DOC
$14.9B
| $1M | ﹤0.01% |
+33,721
| New | +$1.03M |
|
|
BRKL
2245
DELISTED
Brookline Bancorp
BRKL
| $1M | ﹤0.01% |
61,009
+38,197
| +167% | +$546K |
|
|
DS
2246
DELISTED
Drive Shack Inc.
DS
| $999K | ﹤0.01% |
265,590
+242,989
| +1,075% | +$1.07M |
|
2247
Photronics
PLAB
$1.78B
| $998K | ﹤0.01% |
88,349
+76,862
| +669% | +$806K |
|
2248
Resources Connection
RGP
$145M
| $998K | ﹤0.01% |
51,857
-22,127
| -30% | -$354K |
|
|
CTWS
2249
DELISTED
Connecticut Water Service Inc
CTWS
| $997K | ﹤0.01% |
+17,846
| New | +$950K |
|
2250
Progress Software
PRGS
$1.79B
| $992K | ﹤0.01% |
31,067
-97,740
| -76% | -$2.84M |
|
Similar funds
Israel Englander's Q4 2016 Portfolio in Review
As of Q4 2016, Israel Englander held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Israel Englander withdrew a net $7.71B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.
Against the trend, Israel Englander opened a new position in Target worth $175M.
- Israel Englander's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Israel Englander added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Israel Englander's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Israel Englander fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Israel Englander's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Israel Englander opened 858 new positions and closed 801 in Q4 2016.
- Israel Englander's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.